- Home
- FURY vs INCR Comparison
FURY vs INCR Comparison
Compare FURY & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FURY
- INCR
- Stock Information
- Founded
- FURY 2008
- INCR 1994
- Country
- FURY Canada
- INCR Israel
- Employees
- FURY N/A
- INCR N/A
- Industry
- FURY Precious Metals
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- FURY Basic Materials
- INCR Health Care
- Exchange
- FURY Nasdaq
- INCR Nasdaq
- Market Cap
- FURY 84.1M
- INCR 88.9M
- IPO Year
- FURY N/A
- INCR N/A
- Fundamental
- Price
- FURY $0.71
- INCR $1.63
- Analyst Decision
- FURY Strong Buy
- INCR
- Analyst Count
- FURY 2
- INCR 0
- Target Price
- FURY $1.40
- INCR N/A
- AVG Volume (30 Days)
- FURY 586.4K
- INCR 32.8K
- Earning Date
- FURY 08-14-2025
- INCR 08-28-2025
- Dividend Yield
- FURY N/A
- INCR N/A
- EPS Growth
- FURY N/A
- INCR N/A
- EPS
- FURY N/A
- INCR N/A
- Revenue
- FURY N/A
- INCR $65,575,323.00
- Revenue This Year
- FURY N/A
- INCR $69.54
- Revenue Next Year
- FURY N/A
- INCR $41.75
- P/E Ratio
- FURY N/A
- INCR N/A
- Revenue Growth
- FURY N/A
- INCR N/A
- 52 Week Low
- FURY $0.35
- INCR $1.17
- 52 Week High
- FURY $0.72
- INCR $2.07
- Technical
- Relative Strength Index (RSI)
- FURY 78.57
- INCR 53.29
- Support Level
- FURY $0.47
- INCR $1.57
- Resistance Level
- FURY $0.72
- INCR $1.65
- Average True Range (ATR)
- FURY 0.04
- INCR 0.07
- MACD
- FURY 0.02
- INCR -0.01
- Stochastic Oscillator
- FURY 96.08
- INCR 57.50
About FURY Fury Gold Mines Limited
Fury Gold Mines Ltd is a Canadian-focused exploration and development company strategically positioned in three prolific mining regions: James Bay, Quebec; the Golden Triangle, British Columbia; and the Kitikmeot Region Nunavut. Its projects include Eau Claire, Homestake Ridge, Committee Bay, Eleonore South JV, and Gibson MacQuoid.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.